NA

ID: ALA4083965

Chembl Id: CHEMBL4083965

PubChem CID: 137648667

Max Phase: Preclinical

Molecular Formula: C56H68Na4O11

Molecular Weight: 921.18

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCOc1c2cc(C(=O)[O-])cc1Cc1cc(C(=O)[O-])cc(c1OCCCCCCCC)Cc1cc(C(=O)[O-])cc(c1OCCCCCCCC)Cc1cc(cc(C(=O)[O-])c1)C2.[Na+].[Na+].[Na+].[Na+]

Standard InChI:  InChI=1S/C56H72O11.4Na/c1-4-7-10-13-16-19-22-65-50-40-26-38-25-39(29-46(28-38)53(57)58)27-41-33-48(55(61)62)35-43(51(41)66-23-20-17-14-11-8-5-2)31-45-37-49(56(63)64)36-44(30-42(50)34-47(32-40)54(59)60)52(45)67-24-21-18-15-12-9-6-3;;;;/h25,28-29,32-37H,4-24,26-27,30-31H2,1-3H3,(H,57,58)(H,59,60)(H,61,62)(H,63,64);;;;/q;4*+1/p-4

Standard InChI Key:  NKTRYBKCGATERI-UHFFFAOYSA-J

Associated Targets(Human)

TLR4 Tchem Toll-like receptor 4 (970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TLR4 Tchem Toll-like receptor 4/MD-2/CD14 (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 921.18Molecular Weight (Monoisotopic): 920.5075AlogP: 13.37#Rotatable Bonds: 28
Polar Surface Area: 176.89Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.64CX Basic pKa: CX LogP: 15.83CX LogD: 3.89
Aromatic Rings: 4Heavy Atoms: 67QED Weighted: 0.04Np Likeness Score: 0.27

References

1. Sestito SE, Facchini FA, Morbioli I, Billod JM, Martin-Santamaria S, Casnati A, Sansone F, Peri F..  (2017)  Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling.,  60  (12): [PMID:28471658] [10.1021/acs.jmedchem.7b00095]

Source